Minimally Invasive Knee Procedure Linked To Lower Arthritis Pain Scores

For millions of Americans grinding through daily life with aching, swollen knees, the options have long felt like a grim menu: painkillers, injections that wear off, or eventually going under the knife for a joint replacement. Now, a new study published in the journal Radiology points to a possible middle road, a minimally invasive procedure that targets abnormal blood vessels around the knee and was linked to lower pain scores that lasted through the one-year follow-up.

Genicular artery embolization works by threading a tiny, flexible tube through an artery in the groin and into small blood vessels surrounding the knee joint. Once there, doctors inject microscopic particles to block off the abnormal, overgrown blood vessels fueling inflammation behind arthritis pain.

What sets this study apart is the type of particle used: tiny spheres made from gelatin, designed to dissolve quickly after doing their job, potentially reducing the risk of side effects tied to particles that stay in the body permanently.

Researchers tracked 194 patients with knee osteoarthritis who had already tried and failed with standard treatments, physical therapy, anti-inflammatory drugs, and steroid or lubricating injections, for at least three months. Because some patients had both knees treated, the 194 participants accounted for 239 total procedures. On a pain scale of zero to ten, the typical patient started at a seven and ended at a three, a drop that could mean an easier time walking, climbing stairs, or getting through daily routines.

Every Case Was Reviewed by Surgeons and Procedure Specialists Before Treatment

Before anyone was treated, each case was discussed by a team of orthopedic surgeons and image-guided procedure specialists to confirm the patient’s pain was genuinely arthritis-related, that standard care had been exhausted, and that the procedure was appropriate. People with rheumatoid arthritis, significant kidney problems, severe limb-alignment issues, or poor blood flow in the legs were excluded. All 194 participants were then treated at one institution between July and November 2024, with follow-up collected at six weeks, three months, six months, and one year.

Gelatin-based microspheres smaller than a grain of sand were mixed with saline and a contrast agent so doctors could watch them under live X-ray imaging. Five specialists with varying experience levels performed the 239 procedures, targeting a median of four blood vessels each, and were able to treat the intended vessels in all 239 cases.

Pain Scores Fell by Half and Held Steady at One Year

Pain scores dropped from a median of seven at the start to three at twelve months, and improvements held at every follow-up point along the way. Researchers also tracked broader function using a standardized knee scoring system, where higher numbers mean better outcomes. Daily activity scores rose from a median of 53 to 71.5, and quality of life scores more than doubled, from 19 to 40. Between 55% and 80% of patients crossed the threshold at which a score change translates to something a person actually notices in daily life.

Because the study did not compare treated patients with a placebo or usual-care group, the results cannot prove how much of the improvement came from the procedure itself. Natural symptom fluctuation, attentive medical care, and the placebo effect could all play a role, a limitation the authors themselves flag prominently.

Dissolving Particles Showed Far Fewer Side Effects Than Permanent Alternatives

Safety findings were encouraging over the study’s 12-month window. Out of 239 procedures, mild side effects occurred in just 16 cases, mainly temporary skin discoloration near the treated area that cleared up within 24 hours. One patient developed a bruise near the groin access point, and no moderate or severe complications were recorded.

Not all procedures like this use the same blocking agents, and the choice matters. One widely used material is an antibiotic compound that forms crystals when mixed with contrast dye. It works, but comes with drawbacks: limited availability in some countries, concerns about contributing to antibiotic resistance, and unpredictable particle sizes that complicate control.

Permanent microspheres, tiny beads that stay in the body indefinitely, have also been used with documented success. But their permanent nature raises concerns about long-term effects on blood vessels. Skin discoloration occurred in only 6.3% of cases in this study, compared to rates as high as 65% reported in prior studies using permanent particles.

Knee Arthritis Patients Still Waiting for Relief

Knee osteoarthritis affects a large and growing share of the global population, driven by aging, rising obesity rates, and longer lifespans. Total knee replacement surgery remains the standard for severe cases, but it carries real surgical risks, requires months of recovery, and isn’t right for everyone.

Genicular artery embolization has been building momentum as a bridge option for patients who aren’t ready or eligible for surgery, and for whom the usual pain management tools have stopped working. Most participants in this study were older, with a median age of 69, predominantly female, and had been living with symptoms for more than two years before enrolling, a real-world slice of people who had already run out of easy answers. For that group, a procedure that cut pain scores in half and held steady for a year is worth a conversation with their doctor, even as researchers work toward more controlled trials to confirm how much of the improvement came from the treatment itself.

---

Disclaimer: This article is based on a peer-reviewed study and is intended for informational purposes only. It does not constitute medical advice. Readers should consult a qualified healthcare provider before making any decisions about medical treatments or procedures.

---